| Comparative assessment of methods to develop QSARs for the prediction of the toxicity of phenols to Tetrahymena pyriformis MTD Cronin, AO Aptula, JC Duffy, TI Netzeva, PH Rowe, IV Valkova, ... Chemosphere 49 (10), 1201-1221, 2002 | 223 | 2002 |
| Multivariate discrimination between modes of toxic action of phenols AO Aptula, TI Netzeva, IV Valkova, MTD Cronin, TW Schultz, R Kühne, ... Quantitative Structure‐Activity Relationships 21 (1), 12-22, 2002 | 147 | 2002 |
| Novel hits for acetylcholinesterase inhibition derived by docking-based screening on ZINC database I Doytchinova, M Atanasova, I Valkova, G Stavrakov, I Philipova, ... Journal of Enzyme Inhibition and Medicinal Chemistry 33 (1), 768-776, 2018 | 41 | 2018 |
| Modeling of structure–mutagenicity relationships: counter propagation neural network approach using calculated structural descriptors I Valkova, M Vračko, SC Basak Analytica chimica acta 509 (2), 179-186, 2004 | 39 | 2004 |
| Docking‐based design and synthesis of galantamine–camphane hybrids as inhibitors of acetylcholinesterase G Stavrakov, I Philipova, D Zheleva‐Dimitrova, I Valkova, E Salamanova, ... Chemical Biology & Drug Design 90 (5), 709-718, 2017 | 34 | 2017 |
| A novel galantamine-curcumin hybrid as a potential multi-target agent against neurodegenerative disorders R Simeonova, D Zheleva, I Valkova, G Stavrakov, I Philipova, ... Molecules 26 (7), 1865, 2021 | 28 | 2021 |
| Validation through re-docking, cross-docking and ligand enrichment in various well-resoluted MAO-B receptors E Mateev, I Valkova, B Angelov, M Georgieva, A Zlatkov Int J Pharm Sci Res 13, 1000-1007, 2022 | 23 | 2022 |
| Design, Synthesis, In Silico Studies and In Vitro Evaluation of New Indole-and/or Donepezil-like Hybrids as Multitarget-Directed Agents for Alzheimer’s Disease VT Angelova, B Georgiev, T Pencheva, I Pajeva, M Rangelov, N Todorova, ... Pharmaceuticals 16 (9), 1194, 2023 | 10 | 2023 |
| Design, synthesis, biological evaluation and molecular docking of pyrrole-based compounds as antioxidant and MAO-B inhibitory agents E Mateev, B Angelov, M Kondeva-Burdina, I Valkova, M Georgieva, ... Farmacia 70 (2), 2022 | 10 | 2022 |
| Synthesis, 5-HT1A and 5-HT2A receptor affinity and QSAR study of 1-benzhydryl-piperazine derivatives with xanthine moiety at N4 I Valkova, A Zlatkov, K Nędza, I Doytchinova Medicinal Chemistry Research 21, 477-486, 2012 | 10 | 2012 |
| CoMFA Study on Adenosine A2A Receptor Agonists I Doytchinova, I Valkova, R Natcheva Quantitative Structure‐Activity Relationships 20 (2), 124-129, 2001 | 10 | 2001 |
| Synthesis of new N1Arylpiperazine substituted xanthine derivatives and evaluation of their antioxidant and cytotoxic effects L Andonova, I Valkova, D Zheleva-Dimitrova, M Georgieva, G Momekov, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2019 | 8 | 2019 |
| Adenosine A 2A receptor agonists: CoMFA-based selection of the most predictive conformation I Doytchinova, I Valkova, R Natcheva SAR and QSAR in Environmental Research 13 (2), 227-235, 2002 | 8 | 2002 |
| Antimycobacterial activity, in silico ADME evaluation, and docking study of novel thiazolidinedione and imidazolidinone conjugates VT Angelova, T Pencheva, R Buyukliev, EK Yovkova, I Valkova, ... Russian Journal of Bioorganic Chemistry 47, 122-133, 2021 | 7 | 2021 |
| Database enrichments of MAO-B through ensemble docking E Mateev, IVA Valkova, M Georgieva, A Zlatkov Int. J. Pharm. Pharm. Sci 13, 32-35, 2021 | 6 | 2021 |
| Suitable docking protocol for the design of novel coumarin derivatives with selective MAO-B effects EV Mateev, I Valkova, M Georgieva, A Zlatkov Journal of Molecular Docking 1 (1), 40-47, 2021 | 4 | 2021 |
| Endocrine cells in pig’s gallbladder, ductus cysticus and ductus choledochus with special reference to ghrelin MV Gulubova, IV Valkova, KV Ivanova, IG Ganeva, DK Prangova, ... Bulg Chem Commun, 184-90, 2017 | 4 | 2017 |
| Synthesis, Biological Evaluation, Molecular Docking and ADME Studies of Novel Pyrrole-Based Schiff Bases as Dual Acting MAO/AChE Inhibitors E Mateev, M Kondeva-Burdina, M Georgieva, A Mateeva, I Valkova, ... Scientia Pharmaceutica 92 (2), 18, 2024 | 3 | 2024 |
| Quantitative Structure–Neurotoxicity Assessment and In Vitro Evaluation of Neuroprotective and MAO-B Inhibitory Activities of Series N′-substituted 3-(1,3,7 … M Kondeva-Burdina, J Mitkov, I Valkova, L Peikova, M Georgieva, ... Molecules 27 (16), 5321, 2022 | 3 | 2022 |
| RESVERATROL: RECOMMENDING ITS WIDE INCREASE-A PREMATURE DECISION OR NOT? A REVIEW M Georgieva, I Valkova, B Zlatkov, L Andonova, A Zlatkov International Journal of Pharmaceutical Sciences and Research 6 (9), 3641, 2015 | 3 | 2015 |
